Optimized Gradient Waveforms for Tensor-Valued Diffusion MRI Under Time-Dependent Diffusion Using Double-Isotropic Matched Encoding (DIME) onlinelibrary.wiley.com/doi/10.1002/... #hvhebron #onco [Text complet]

Primary Melanoma Stage as a Predictor of Survival in Advanced Disease: Findings from the Spanish Melanoma Registry GEM1801. www.sciencedirect.com/science/arti... #hvhebron #onco

Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis. www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]

Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy. ashpublications.org/bloodadvance... #hvhebron #onco [Text complet]

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). www.nature.com/articles/s41... #hvhebron #onco [Text complet]

Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy. ascopubs.org/doi/10.1200/... #hvhebron #onco [Text complet]

Natural History After Likely Cure Versus Recurrence After Prostate Radiotherapy (RAPTOR). euoncology.europeanurology.com/article/S258... #hvhebon #onco

Germ line landscape stratification defines distinct molecular and prognostic groups in therapy-related myeloid neoplasms ashpublications.org/bloodadvance... #hvhebron #onco [Text complet]

Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung) www.sciencedirect.com/science/arti... #hvhebron #onco

Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial. www.nature.com/articles/s41... #hvhebron #onco [Text complet]

Peripheral Blood as the Sole Source for Cancer Neoantigen and Reactive T-Cell Discovery. aacrjournals.org/cancerdiscov... #hvhebron #onco [Text complet]

Optimized Gradient Waveforms for Tensor-Valued Diffusion MRI Under Time-Dependent Diffusion Using Double-Isotropic Matched Encoding (DIME). onlinelibrary.wiley.com/doi/10.1002/... #hvhebron #onco [Text complet]

Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial. www.nature.com/articles/s41... #hvhebron #onco [Text complet]

Consolidative allogeneic HCT vs. a watch-and-wait approach for B-cell acute lymphoblastic leukemia patients with early loss of B-cell aplasia after CAR T-cell therapy. www.nature.com/articles/s41... #hvhebron #onco #hemat

Genetic Variation in NR1I2 and Palbociclib Safety and Prognosis in Advanced Breast Cancer: An Exploratory Multicenter Study. www.mdpi.com/1422-0067/27... #hvhebron #onco [Text complet]

STELLAR-311: a randomized phase II/III study of zanzalintinib versus everolimus in advanced neuroendocrine tumors. www.tandfonline.com/doi/full/10.... #hvhebron #onco [Text complet]

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy. www.mdpi.com/2072-6694/18... #hvhebron #onco [Text complet]

Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission. www.sciencedirect.com/science/arti... #hvhebron #onco

Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure. www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]

Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study). link.springer.com/article/10.1... #hvhebron #onco